Drug Trial Radar · NCT05636176
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation
Last checked: Nov 19, 2026Latest source record: Oct 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
4,874
Actual
Start
May 8, 2023
Primary completion
Sep 3, 2026
Study completion Sep 3, 2026
Sponsor
- Lead sponsor
- Novo Nordisk A/SNovo Nordisk (NVO)
- Sponsor type
- Industry
- First posted
- Dec 5, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will be done to see if ziltivekimab can be used to treat people living with heart failure and inflammation. Participants will either get ziltivekimab or placebo. Participants will get study medicine for once-monthly injections either in a pre-filled syringe to inject the study medicine into a skinfold or a pen-injector to inject the study medicine into flat skin. The study is expected to last for up to 4 years. Participants will have up to 20 clinic visits. Participants will have to use a study app on their phone to record and share information about all their injections of study medicine and to fill in questionnaires.
Conditions
- Heart Failure
Interventions
ZiltivekimabDrug
Ziltivekimab subcutaneous (s.c.) injection in a pre-filled syringe or a pen-injector once-monthly for up to 4 years.
PlaceboDrug
Ziltivekimab placebo s.c. injection in a pre-filled syringe or a pen-injector once-monthly for up to 4 years.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to First Occurrence of a Composite Heart Failure Endpoint Consisting of: Cardiovascular (CV) Death, Heart Failure (HF) Hospitalisation or Urgent HF VisitTime frame: From randomisation (month 0) to end of study (up to 48 months)
Locations
1,013 sites in 46 countries. Site status is shown where the registry gives one.
Advanced Cardiovascular, LLC
Alexander City, Alabama
Eastern Shore Rsrch Inst, LLC
Fairhope, Alabama
Heart Center Rsrch_Hunstville
Huntsville, Alabama
Banner University Medical Ctr
Phoenix, Arizona
Cardiology & Medicine Clinic
Little Rock, Arkansas
InvivoCure -2
Alhambra, California
National Heart Institute Cal
Beverly Hills, California
Valley Clinical Trials
Covina, California
Scripps Memorial Hospital La Jolla
La Jolla, California
Purushotham & Akther Kotha MD, inc.
La Mesa, California
VA Loma Linda Hlthcr Sys
Loma Linda, California
Biopharma Clinical Research Services, LLC
Los Angeles, California
VA Greater Los Angeles Hlthcare System
Los Angeles, California
VAGrtrLosAngelesHlthcareSystem
Los Angeles, California
Valley Clinical Trials, Inc.
Northridge, California
UCI Health
Orange, California
Stanford Univ School of Med
Palo Alto, California
San Diego Cardiac Center
San Diego, California
North America Research Institute
San Dimas, California
Manshadi Heart Institute
Stockton, California
Lundquist Inst-Biomed Innovtn
Torrance, California
InvivoCure
Van Nuys, California
Rocky Mountain Regional VAMC
Aurora, Colorado
InvivoCure -2
Denver, Colorado
S Denver Cardiology Associates
Littleton, Colorado
Bridgeport Hospital
Bridgeport, Connecticut
Cardiology Associates of Fairfield County
Stamford, Connecticut
Pioneer Clinical Studies-Coral Gables
Coral Gables, Florida
Nature Coast Clin Rsrch_Crystal River
Crystal River, Florida
Integrative Research Assoc Inc
Fort Lauderdale, Florida
New Generation of Medical Research
Hialeah, Florida
Memorial Region Hosp_Hollywood
Hollywood, Florida
E Coast Inst for Rsrch LLC_Jacksonville
Jacksonville, Florida
Jacksonville Ctr for Clin Res
Jacksonville, Florida
Baptist Health Research Institute
Jacksonville, Florida
Baptist Health South Florida
Miami, Florida
Pioneer Clinical Studies-Coral Gables
Miami, Florida
NCH Research Institute
Naples, Florida
Amavita Research Services, LLC
North Miami Beach, Florida
Ocala Cardiovascular Research
Ocala, Florida
Showing 40 of 1,013 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.